Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study.
Journal Information
Full Title: J Neuroimmunol
Abbreviation: J Neuroimmunol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Allergy and Immunology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declaration of Competing Interest AA, MD, SM, DM, SF received research support from Bristol Myers Squibb, Roche, 10.13039/100006314Biogen Idec, Sanofi-Genzyme, and Merck, none related to this study. MM, SDA, GH, UG, DG, PS, RZF, MG report no conflict of interest."
"Funding This study was supported by research grants from Sheba MS Center, and the Laura Schwarz-Kipp Research Fund for Autoimmune Diseases, Sackler 10.13039/100008235Faculty of Medicine, Tel-Aviv University, Israel. Sapir Dreyer-Alster is supported by a research grant from the Clair and Amedee Maratier Institute for the study of Blindness and Visual Disorders, Sackler Faculty of Medicine, Tel-Aviv University, Israel."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025